 It's easier for the small company, with a high risk, to start off as a university spinoff. The Tech is a company established to commercial technology that Lothar and I developed. The product that the company currently provides for the researchers on the market is a kit. It's a set of the reagents that allow scientists in their laboratory to detect DNA methylation over the specific gene targets that they are interested in. Being a university spinoff has a pretty big advantage. We don't have to start a new laboratory where we have to have it all up and running again. We can continue the research we have done and actually use the same facilities. One of the big challenges is that the research that is being conducted here at the university is a high degree of basic research. The technology that comes out of the university is at a very early stage. It's difficult to get it commercialised. One of the tools we use to change technology is to create a spin-out effect. In spin-out effect, there is a possibility to attract investors and get the technology changed. From the university time, we help researchers in their laboratory to enable them to establish their own company. When the first company is established, we release it and then it's a company on its own and just like everyone else in the country. How innovation is one of the four Danish innovation countries. We set the world to invest in early technological startups, for example spin-outs from universities. It's an absolute advantage that universities themselves are involved in supporting spin-outs. One of the features of the technology transfer function at the university is that it helps to make a management plan. The other thing that is at least so important is that when we create a spin-out for the university that the company still has access to laboratories and facilities and also some of the researchers, because we simply don't have the means to finance a complete organization and then start it. The dynamic, the learning and the change of this system is something that you see in a lot of hospitals and it's both cancer, of course, but it's diabetes, heart attack hospitals, psychiatric hospitals and so on. So the potential for the applications of the technology in the future is huge.